With the utmost respect because I know you are long and
With the utmost respect because I know you are long and i've seen you around and respect all that you do. Please though tell me how a company loses nearly 80% of their market cap over a month and a half in a steady sweep and has all this ammo and does little to nothing. Then has a leadership change and fails to issue a 8k stating the reason. Holiday or not if they can update the site to reflect the change they can issue an 8k. I'm not bashing. Trust me I'm far from it, but I am frustrated. SO VERY GRATEFUL for the fun today. 100k that was red is now back in my accounts and not done yet. But this run isn't a result of any market management that they have done to control the valuation of the company. I work in healthcare. Patients are first always but I'm also in operations and an investor and I know that Quality Care keeps the doors unlocked and operations keeps the lights on. Without protecting market cap I don't care if you are a mega ship. If you have a whole in the hull eventually you will sink unless it's fixed. The last month and a half with nearly 80% reduction in the highest market cap is no small whole. It should say something to release AMAZING results (I still don't think everyone realizes how spectacular they really are) and for the price to fall. OWCP has ammo for miles. If you use enough of it early then you don't have to bring out the bombs. Something has to have happened for this strong of a reversal but if it hadn't then where would we be. We will know more and I'm grateful but imagine if OWCP had mitigated the risk and we only lost 40% and started this run at 1.20. So not bashing at all but expressing my disappointment that I don't feel that a company I've poured over a quarter of a million dollars in because I believe in them from all the D&D didn't do more to protect market value. They know they will need money and FDA approval is expensive. They are also incredibly cleaver which is why I invested in them. But that is a resource and value added to the PPS. Not using small burst of their PR ammo that is true PR and not fluff to prevent the slaughter that occurred seems contrary to their overall objectives to me. All i'm saying is that if I'm feeling it or thinking it... I'm usually the last... which means others have too. I think we have a brilliantly cleaver leadership team and amazing true potential which is the only reason I hung on. My average share price is near 2 dollars. (could have been wiser but whatever) I think I have a right to express frustration when I invested more and held through potential losses much larger than most who have gotten into the company. As Feller said this morning something along the lines of they likely got the point. I hope they did. I believe in them and think highly of them and for all their strategy and intelligence it makes me question why this extreme was allowed to take place.
I just want word that its recognized and changes are being made to ensure that an 80% drop in market cap will not happen again from a lack of intervention. I mean United Airlines beat some dude up and the CEO made a fool of himself and the share prices didn't see that kind of loss. Now I get the difference between OTC and NasDaq but isn't that were we are going. If you are going to play like the big boys it's time to act like one.
Again I respect you Triple 9 and with the reversal I'm very glad to see and say that things are looking up and are only STARTING to come in line with where they need to be. We both know what we own. I'm not a low price holder and I have worked very hard for every penny I have made. I always try to place my funds in support of the things I believe in with people who will work just as hard as I have while not bull Sh*ting me. OWCP is that place I've chosen as everyone here.
Again... Nothing but respect but we all see it as an issue and would have all liked to have started this run from 1.20 instead of 50 cents.
We got legs we will run... losses will be covered... just hope mistakes will be corrected.
3
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Ritchie's Recognition: An Ongoing Leadership Journey When leadership is genuine, it resonates through the ranks all the way to the community. That's exactly what Meredith Ritchie, EVP at Alliant Credit Union, has been doing—and it shows as she nabs the Chicago Titan 100 accolade yet again in 2027. These folks at Titan 100 don’t hand out participation trophies;...
Continue Reading
Robotic Mowers Meet Tech Mastery In the never-ending quest to tech-up every corner of our lives, robotic mowers are carving out their patch of the market—thanks in no small part to Fibocom and Suntek teaming up like a couple of tech-savvy gardeners. Here’s the lowdown: In Munich, during the electronica 2026 show, these two companies showcased how they’re making...
Continue Reading
From Idea to Relaxed Tails: Enter THE PAW FREE SCRATCHER Strolling along the bustling streets of Pittsburgh, it's the kind of idea that hits you when you least expect it. The endless days spent scratching your furry buddy, only to realize you're the one more tuckered out. Some inventive soul from Puyallup, Washington, decided to tackle this furry fatigue head-on. They've...
Continue Reading
Analyzing Telecom Argentina's Financial Turmoil Telecom Argentina's nine-month stretch of 2026 wasn’t a smooth sail by any stretch. The powerhouse saw a consolidated net loss of P$56,615 million for the third quarter while bagging a net income of P$862,959 million across the broader period. Talk about volatility. It's a classic case of juggling financial fire,...
Continue Reading
Breaking Free from Animal-Derived Components It feels like every biotech firm out there wants to ditch animal components these days, and TheWell Bioscience is no exception. With their new RocketCell™ S1, S2, and S3 supplements, they're diving headlong into the trend of animal origin-free (AOF) cell culture solutions. It's a smart move for researchers frustrated by the...
Continue Reading
Battle-tested Expertise Joins SVP's Ranks Whatever way you slice it, personnel like Shigesuke Kashiwagi don't come around every day. When an outfit like Strategic Value Partners welcomes a heavyweight like him as a Senior Advisor, it's definitely worth a closer look. With decades of financial machinations under his belt, including pivotal roles at Nomura and Schroders,...
Continue Reading
Seeking Serenity: The Essence of Kayon Valley Caught in the whirlwind of modern life, couples often find themselves yearning for tranquility—a place to reconnect away from the rigmarole. Enter The Kayon Valley Resort in Ubud, Indonesia, newly crowned as the Best Honeymoon Resort 2026. This spot isn't just another pin on the map, it’s a refuge where wellness and...
Continue Reading
Pentixapharm and Eckert & Ziegler's Extended Bond Play Fresh off the Berlin newswire, Pentixapharm Holding AG made a bold move with Eckert & Ziegler SE (EZAG). This isn't your everyday handshake, folks. We're talking about extending a 4.00% convertible bond from 2027 all the way out to 2030. There's a twist: the interest rate's ticking up to 6.00% starting in 2027. So,...
Continue Reading
Navigating the Turbulent Waters of Note Exchanges Well folks, it looks like JELD-WEN Holding, Inc. is making waves again. The company has decided to shake things up a bit with a new twist on the note exchange comedy script. They’re altering the terms of the late exchange consideration for their outstanding 4.875% Senior Notes due 2027, making the latecomers to the party...
Continue Reading
Thriving in a Complex Energy World You know, for Frontera Energy Corporation, it's not just about tossing around tanker loads of cash—it’s about working those numbers into something real. Their Q3 2026 gives us a peep into how they’re keeping the hot iron pressed against opportunity. With a net income of $11.7 million and adjusted EBITDA jumping 16% to top $34.8...
Continue Reading
Top 5 Most Recently Viewed Articles
Tezspire’s Role in Managing Chronic Rhinosinusitis Recent breakthroughs in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) show promising results with Tezspire (tezepelumab-ekko), a groundbreaking therapy. This innovative medication has demonstrated remarkable efficacy in alleviating symptoms and reducing the severity of nasal polyps, marking a...
Continue Reading
eInfochips Earns Recognition in Quality Engineering Services eInfochips, a renowned provider of product engineering and digital transformation services, recently announced its place in the notable Gartner Market Guide for Quality Engineering Services. This achievement highlights eInfochips' dedication to delivering exceptional quality and innovative solutions to clients...
Continue Reading
Opportunity for Investors in DoubleVerify Holdings, Inc. Rosen Law Firm, a well-respected investor rights law firm, has announced a significant opportunity for purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV). This notification is aimed at those who bought shares between November 10, 2023, and February 27, 2025. It is crucial for these investors to be...
Continue Reading
Fingrid's Commitment to a Sustainable Future Fingrid, as Finland's transmission system operator, is dedicated to ensuring the reliability and sustainability of electricity supply throughout the nation. As part of its commitment to transparency and accountability, the company publishes detailed Management Reviews every six months, providing insights into its financial and...
Continue Reading
Decisions at Coloplast A/S Annual General Meeting Recently, Coloplast A/S convened its Annual General Meeting (AGM), where significant resolutions were adopted that will shape the company's future. This gathering marked an important event for stakeholders, emphasizing the company's dedication to transparency and responsible governance. Approval of Financial Reports One of...
Continue Reading